Davita Clinical Research hires four

Monday, August 20, 2012 02:33 PM

DaVita Clinical Research (DCR), a provider of clinical research services focused on kidney research, has hired four individuals to ignite the expansion of DCR at its latest clinical research facility in Denver, Colo. The new team members include: Dr. Christopher Galloway, medical director; Chad Jaeger, senior director of clinical operations; Amy Denvir, director of operations-Denver; and Michael Kreuter, director of data management.

Galloway brings to DCR more than 12 years of medical practice, including six years within emergency and critical care. Before accepting the medical director position at DCR, he served as an attending physician for Capitol Emergency Associates in Austin, Texas, Front Range Emergency Associates in Colorado Springs, Colo., and the University of Tennessee in Knoxville.

Jaeger’s involvement within the early clinical research industry spans the past 16 years in both clinical and commercial operations and includes former employers Harris Laboratories, MDS Pharma Services and Radiant Research. His last position prior to joining DCR as senior director of clinical operations, was senior account executive for Covance’s early clinical pharmacology units. Jaeger is also a member of the American Society for Clinical Pharmacology and Therapeutics (ASCPT).

As the director of operations-Denver, Denvir will utilize more than 20 years of early phase CRO industry experience to successfully launch the new Denver facility and ensure good clinical practice (GCP) is maintained. Denvir formerly worked for Metroplex Clinical Research Center, Covance, Radiant Research and MDS Pharma Services in a variety of operational leadership roles.

Before joining DCR as director of data management, Kreuter held various senior level data management positions, spanning 16 years, at several organizations: Sanofi Pasteur, M3 Clinical Research and SDI.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 15

WIRB-Copernicus Group acquires New England IRB

BBK Worldwide secures $3 million in private á¼€nancingto accelerate its global and technological expansion

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs